PRINTER'S NO. 317
THE GENERAL ASSEMBLY OF PENNSYLVANIA
SENATE BILL
No.
335
Session of
2019
INTRODUCED BY SCHWANK, FOLMER, STREET, COSTA, FONTANA, ARGALL,
FARNESE, HUGHES, BROWNE, YUDICHAK, TARTAGLIONE, HAYWOOD AND
BREWSTER, FEBRUARY 26, 2019
REFERRED TO AGRICULTURE AND RURAL AFFAIRS, FEBRUARY 26, 2019
AN ACT
Allowing for use of industrial hemp in this Commonwealth.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Short title.
This act shall be known and may be cited as the Industrial
Hemp Act.
Section 2. Definitions.
The following words and phrases when used in this act shall
have the meanings given to them in this section unless the
context clearly indicates otherwise:
"Industrial hemp." A plant of the genus cannabis and any
part of the plant, whether growing or not, containing a delta-9
tetrahydrocannabinol concentration of not more than 0.3% on a
dry-weight basis.
"Product." A finished product containing industrial hemp
which:
(1) Is a cosmetic, food, food additive or herb.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
(2) Is for human use or consumption.
(3) Contains any part of the hemp plant, including
naturally occurring cannabinoids, compounds, concentrates,
extracts, isolates, resins or derivatives.
(4) Contains a delta-9 tetrahydrocannabinol
concentration of not more than 0.3%.
Section 3. Manufacturing of food products.
Each manufacturer of food containing industrial hemp must
comply with the following:
(1) Each part of the hemp plant utilized in the food
product must come from a state that has an established and
approved industrial hemp program or a country that inspects
or regulates hemp under food safety or equivalent criteria to
ensure safety for human consumption.
(2) The industrial hemp's producer or grower must be in
good standing and in compliance with the governing laws with
the state or country of origin.
(3) The industrial hemp, each part of the industrial
hemp plant used and the finished product must not contain
more than 0.3% delta-9 tetrahydrocannabinol.
(4) The product must be labeled in accordance with
Federal and State labeling laws and in accordance with the
following:
(i) Clear identification that the product contains
hemp.
(ii) Clear identification that the product contains
cannabidiol and the percentage of cannabidiol if added to
the product.
(iii) The statement "The FDA has not evaluated this
product for safety or efficacy."
20190SB0335PN0317 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Section 4. Abrogation of rules.
All regulations are abrogated to the extent of any
inconsistency with the provisions of this act.
Section 5. Repeal.
All acts and parts of acts are repealed insofar as they are
inconsistent with this act.
Section 6. Effective date.
This act shall take effect in 60 days.
20190SB0335PN0317 - 3 -
1
2
3
4
5
6
7
8